83 related articles for article (PubMed ID: 23422352)
21. Proteome Alterations of Hippocampal Cells Caused by Clostridium botulinum C3 Exoenzyme.
Schröder A; Rohrbeck A; Just I; Pich A
J Proteome Res; 2015 Nov; 14(11):4721-33. PubMed ID: 26393427
[TBL] [Abstract][Full Text] [Related]
22. Cell Entry of C3 Exoenzyme from Clostridium botulinum.
Rohrbeck A; Just I
Curr Top Microbiol Immunol; 2017; 406():97-118. PubMed ID: 27832378
[TBL] [Abstract][Full Text] [Related]
23. Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions.
Barth H; Fischer S; Möglich A; Förtsch C
Front Immunol; 2015; 6():339. PubMed ID: 26175735
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
25. Clostridial C3 Toxins Enter and Intoxicate Human Dendritic Cells.
Fellermann M; Huchler C; Fechter L; Kolb T; Wondany F; Mayer D; Michaelis J; Stenger S; Mellert K; Möller P; Barth TFE; Fischer S; Barth H
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32883045
[TBL] [Abstract][Full Text] [Related]
26. The Binary Toxin CDT of
Beer LA; Tatge H; Schneider C; Ruschig M; Hust M; Barton J; Thiemann S; Fühner V; Russo G; Gerhard R
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865182
[TBL] [Abstract][Full Text] [Related]
27. Vimentin mediates uptake of C3 exoenzyme.
Rohrbeck A; Schröder A; Hagemann S; Pich A; Höltje M; Ahnert-Hilger G; Just I
PLoS One; 2014; 9(6):e101071. PubMed ID: 24967582
[TBL] [Abstract][Full Text] [Related]
28. Changes in ADP-ribosylation of rho-related protein by exoenzyme C3 from Clostridium botulinum with maturation in rat testis.
Kurokawa T; Yamashita A; Sato E; Goto M; Ishibashi S
Biochem Int; 1992 Sep; 27(6):1067-71. PubMed ID: 1445375
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
30. Purification of TAT-C3 exoenzyme.
Sahai E; Olson MF
Methods Enzymol; 2006; 406():128-40. PubMed ID: 16472655
[TBL] [Abstract][Full Text] [Related]
31. Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase.
Wiegers W; Just I; Müller H; Hellwig A; Traub P; Aktories K
Eur J Cell Biol; 1991 Apr; 54(2):237-45. PubMed ID: 1908779
[TBL] [Abstract][Full Text] [Related]
32. C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells.
Fahrer J; Schweitzer B; Fiedler K; Langer T; Gierschik P; Barth H
Bioconjug Chem; 2013 Apr; 24(4):595-603. PubMed ID: 23506195
[TBL] [Abstract][Full Text] [Related]
33. Release of astroglial vimentin by extracellular vesicles: Modulation of binding and internalization of C3 transferase in astrocytes and neurons.
Adolf A; Rohrbeck A; Münster-Wandowski A; Johansson M; Kuhn HG; Kopp MA; Brommer B; Schwab JM; Just I; Ahnert-Hilger G; Höltje M
Glia; 2019 Apr; 67(4):703-717. PubMed ID: 30485542
[TBL] [Abstract][Full Text] [Related]
34. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile.
Just I; Selzer J; von Eichel-Streiber C; Aktories K
J Clin Invest; 1995 Mar; 95(3):1026-31. PubMed ID: 7883950
[TBL] [Abstract][Full Text] [Related]
35. Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates.
Bade S; Rummel A; Reisinger C; Karnath T; Ahnert-Hilger G; Bigalke H; Binz T
J Neurochem; 2004 Dec; 91(6):1461-72. PubMed ID: 15584922
[TBL] [Abstract][Full Text] [Related]
36. Efficient production of Clostridium botulinum exotoxin C3 in bacteria: a screening method to optimize production yields.
Gadea G; Boublik Y; Delga S; Roux P
Protein Expr Purif; 2005 Mar; 40(1):164-8. PubMed ID: 15721784
[TBL] [Abstract][Full Text] [Related]
37. Rho-modifying C3-like ADP-ribosyltransferases.
Aktories K; Wilde C; Vogelsgesang M
Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
[TBL] [Abstract][Full Text] [Related]
38. Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.
Böhmer J; Jung M; Sehr P; Fritz G; Popoff M; Just I; Aktories K
Biochemistry; 1996 Jan; 35(1):282-9. PubMed ID: 8555186
[TBL] [Abstract][Full Text] [Related]
39. ADP-ribosylation of rho by C3 ribosyltransferase inhibits IL-2 production and sustained calcium influx in activated T cells.
Angkachatchai V; Finkel TH
J Immunol; 1999 Oct; 163(7):3819-25. PubMed ID: 10490980
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones.
Ahnert-Hilger G; Höltje M; Grosse G; Pickert G; Mucke C; Nixdorf-Bergweiler B; Boquet P; Hofmann F; Just I
J Neurochem; 2004 Jul; 90(1):9-18. PubMed ID: 15198662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
